Original Report

Southeast Asian ovalocytosis is associated with increased expression of Duffy antigen for chemokines (DARC)

I.J. Woolley, P. Hutchinson, J.C. Reeder, J.W. Kazura, and A. Cortés

The Duffy antigen receptor for chemokines (DARC or Fy glyco- RBC morphology.3 SAO is widespread in several popula- ) carries antigens that are important in tions of Papua New Guinea (PNG), where its prevalence and is the main receptor used by Plasmodium vivax to invade correlates with endemicity and altitude.4 In these reticulocytes. Southeast Asian ovalocytosis (SAO) results from populations, homozygosity is apparently incompatible with an alteration in RBC membrane protein band 3 and is thought to full development of the fetus inasmuch as no persons ho- mitigate susceptibility to falciparum malaria. Expression of some RBC antigens is suppressed by SAO, and we hypothesized that mozygous for the band 3 mutation have yet been described, SAO may also reduce Fy expression, potentially leading to reduced but heterozygosity confers strong protection against cere- susceptibility to vivax malaria. Blood samples were collected from bral malaria.5,6 Although early studies had suggested that individuals living in the Madang Province of Papua New Guinea. the SAO trait may afford some protection against vivax or Samples were assayed using a flow cytometry assay for expres- falciparum parasitemia,7–9 other studies did not support sion of Fy on the surface of RBC and reticulocytes by measuring this hypothesis.10 The mechanism of protection against the attachment of a phycoerythrin-labeled Fy6 antibody. Reticu- cerebral malaria is not completely understood,11,12 but the locytes were detected using thiazole orange. The presence of the specific protection against cerebral malaria suggests that it SAO mutation was confirmed by PCR. There was a small (approxi- may operate by means of alterations in sequestration of in- mately 10%) but statistically significant (p=0.049, Mann-Whitney U test) increase in Fy expression on SAO RBC compared with RBC fected RBC. However, SAO confers limited or no protection from individuals without this polymorphism: mean Fy expres- against placental malaria, which is also linked to sequestra- sion (mean fluorescence intensity [MFI]) was 10.12 ± 1.22 for SAO tion of infected RBCs.13,14 heterozygotes versus an MFI of 8.95 ± 1.1 for individuals without Individuals whose RBCs are negative for expression of SAO. For reticulocytes the MFI values were 27.61 ± 19.12 for SAO Duffy antigens illustrate homozygote advantage for vivax heterozygotes and 16.47 ± 3.81 for controls. SAO is associated with malaria in that their RBCs are completely refractory to in- increased and not decreased Fy6 expression so that susceptibility vasion by Plasmodium vivax.15 Historic serologic data sug- to P. vivax infection is unlikely to be affected. gest expression of some antigens on human RBCs was sup- Immunohematology 2009;25:63–66. pressed by the SAO trait, but expression of Duffy antigens did not appear suppressed as determined by the less sensi- Key Words: Duffy, Southeast Asian ovalocytosis, antigen tive serologic instruments available at that time.16 In those expression studies, antibodies of varying specificities were placed in tubes using serial dilution, and results were read macro- n 1949 Haldane proposed that malaria had a dramatic scopically with the aid of an eyepiece using a standard- influence on the , by selecting forge- ized scoring system. In this study, we used molecular and netic polymorphisms that were known or suspected to I cytometric techniques to diagnose SAO and to reexamine protect against malaria.1 Although some of these polymor- whether there was a difference in expression of Duffy an- phisms can be detrimental when individuals are homozy- tigen receptor for chemokines (DARC) between SAO and gous, e.g., sickle anemia, their apparent selection in hu- control individuals in the context of possible differential man populations living in malaria-endemic areas is evidence susceptibility to infection with different Plasmodium spe- that they offer some protection against death from malaria, cies an infectious disease that continues to kill more than 1 mil- lion persons annually.2 Critical to this theory is the concept Materials and Methods of heterozygote advantage. That is, carriage of the mutant Blood was collected by venipuncture in CPD anticoag- on one member of a chromosomal pair is beneficial ulant or by finger prick using a BD Microtainer (Becton whereas homozygosity is deleterious. An extreme example Dickinson, San Jose, CA) with EDTA anticoagulant from of heterozygote advantage in Melanesian populations is healthy volunteers from two villages, Sempi and Bemlon, Southeast Asian ovalocytosis (SAO), a hereditary form of on the north coast of the Madang Province, PNG. Oral in- ovalocytosis that is caused by a 27- deletion in the formed consent was obtained after approval for the study gene encoding the major integral RBC membrane protein by the Medical Research Advisory Committee of the PNG band 3 (AE1, SLC4A1), leading to a distinctive change in

IMMUNOHEMATOLOGY, Volume 25, Number 2, 2009 63 I.J. Woolley et al.

Ministry of Health. After collection, samples were kept on Table 1. Mean fluorescence intensity (± standard deviation) of Fy6 ice or refrigerated at 4°C. Within 1 week, flow cytometric antibody binding to erythrocytes and reticulocytes studies were undertaken with antibody to Fy6 (kindly pro- All Subjects All Subjects vided by John Barnwell, CDC, Atlanta, GA). This is a mouse (Reticulocytes) (Erythrocytes) that attaches to the first extracellular SAO heterozygotes (N = 19) 27.61 ± 19.12 10.12 ± 1.22 domain of the Fy glycoprotein, in an area thought to cor- Non-SAO individuals (N = 20) 16.47 ± 3.81 8.95 ± 1.1 17,18 respond to the binding site of P. vivax merozoites. The P value for difference (Mann- 0.65 0.0487 antibody was conjugated directly to a phycoerythrin (PE) Whitney U test) label (Prozyme, San Leandro, CA) according to the manu- facturer’s instructions. A 5-µL aliquot of blood was washed three times in 50 µL of PBS and pelleted. RBCs were incu- Discussion bated with 50 µL of a 1 in 50 dilution of Fy6 antibody for 15 The main finding of this study was that the SAO trait minutes at 37°C. Cells were then washed twice in PBS and does not result in reduced expression of Fy antigen. In fact, resuspended in thiazole orange (TO) solution according to we observed a 10 percent increase (p=0.049) in Fy antigen the manufacturer’s specifications (Becton Dickinson). The expression by SAO RBCs when compared with RBCs from samples were analyzed on a flow cytometer (Mo-Flo, Da- non-SAO individuals from the same area. This difference koCytomation, Fort Collins, CO) equipped with a 70-mW was significant when expression by all RBC populations air-cooled argon ion laser at 488 nm. TO fluorescence was was evaluated but not when only SAO reticulocytes were read with a 525-nm bandpass optical filter and PE fluores- compared with non-SAO reticulocytes (although a sugges- cence with a 570-nm bandpass filter. Compensation was tive trend existed). As anticipated, reticulocyte expression applied, and negative fluorescence signals were adjusted of Fy6 antigen exceeded RBC expression.20 The reasons for until they were orthogonal. Forward-scatter, side-scatter, the increased RBC Fy6 antigen expression in SAO are un- and fluorescence data were analyzed. A count of 5000 TO- clear at present, but it may reflect either a decreased rate of positive cells was taken per sample. This was approximately loss of Fy6 antigen from the surface of SAO RBC relative to 1 to 2 percent of the total number of cells assayed for each control RBC, perhaps in relation to the increased rigidity of individual. Beads of known immunofluorescence (Immu- the SAO cell wall, or differences in the surface area of ovalo- no-Brite, Coulter, Puerto Rico) were used to standardize cytes versus non-SAO RBC. Because there was only a small experiments undertaken at different times. Detection of the increase in Fy6 antigen expression on SAO RBC and there SAO mutation was undertaken using previously described was no statistically significant increase in the reticulocyte PCR methods.19 Experienced microscopists from the PNG subpopulation, which is the only subpopulation susceptible Institute of Medical Research performed microscopic to infection by P. vivax, it is unlikely that this alteration af- inspection of Giemsa-stained blood films for malaria para- fects susceptibility to this parasite, although there is other sites. Statistical analysis was undertaken by using SPSS in vitro evidence that alterations in numbers of Fy antigens (Statview 4.51, Abacus Concepts, Berkeley, CA). We have expressed may alter that susceptibility.21 It is not surprising used nonparametric testing because we do not have evi- that the difference in Fy levels was not shown in the paper dence for normal distribution of DARC abundance in the of Booth et al.16 because they were using less sensitive se- surface of SAO erythrocytes. rologic methods or because Fy6 antigen is more available or more expressed in SAO ovalocytosis over the antigens Results tested in the previous study. However, their findings with Samples from 19 SAO heterozygotes and 20 non-SAO respect to other antigens, including Rh polypeptides, have donors were examined. Mean age of donors did not dif- subsequently been confirmed by molecular techniques.22 fer significantly between the two groups (mean age, 29.32 Fy antigen negativity caused by homozygosity for a pro- ± 13.70 years for SAO heterozygotes versus 26.91 ± 11.80 moter mutation that silences of the FY gene23 years for non-SAO individuals). Four individuals had ma- is observed in many ethnic groups in sub-Saharan , laria infection based on inspection of blood smears. One and presumably accounts for the relative lack of vivax ma- SAO and one non-SAO individual had Plasmodium malari- laria in this part of the world. The apparently independent ae, and two non-SAO donors had . emergence of heterozygosity for this same muta- SAO RBC showed increased expression of Fy glycoprotein tion has also been described in the Wosera area of PNG, relative to non-SAO RBC as measured by binding of the Fy6 where SAO is rare or nonexistent. There is a need for further monoclonal antibody (Table 1). The level of Fy6 antigen evaluation of whether other common RBC polymorphisms was also higher in SAO reticulocytes compared with control affect Fy antigen expression, especially those that are as- reticulocytes, but the difference was not statistically sig- sociated with changes in RBC shape and surface area. For nificant (Table 1). Subsequent analysis of the data did not example, α-thalassemia is common in PNG, and in many suggest the differences were caused by a systemic bias at- areas, including the Madang Province, nearly all individuals tributable to sex, village of origin, or method of obtaining have the typical α-globin mutation seen in Melanesians.24 It blood (data not shown).

64 IMMUNOHEMATOLOGY, Volume 25, Number 2, 2009 SAO and DARC seems unlikely that this common polymorphism would act 9. Serjeantson S, Bryson K, Amato D, Babona D. Malaria as a confounding factor in our study on the grounds of bio- and hereditary ovalocytosis. Hum Genet 1977;37:161– logic plausibility, low likelihood of linkage disequilibrium, 7. and very high prevalence in the region (assuming therefore 10. Foo LC, Rekhraj V, Chiang GL, Mak JW. Ovalocytosis more or less equal distribution between SAO and control protects against severe malaria parasitemia in the Ma- individuals within the population studied). Finally, it will layan aborigines. Am J Trop Med Hyg 1992;47:271–5. be important to determine whether environmental vari- 11. Cortes A, Benet A, Cooke BM, Barnwell JW, Reeder JC. ables extant in malaria-endemic populations might change Ability of Plasmodium falciparum to invade Southeast Fy antigen expression. Another example would be iron defi- Asian ovalocytes varies between parasite lines. Blood ciency, which is prevalent in PNG and many other malaria- 2004;104:2961–6. endemic regions of the world. 12. Cortes A, Mellombo M, Mgone CS, Beck HP, Reeder JC, There is evidence that the SAO trait affects several steps Cooke BM. Adhesion of Plasmodium falciparum– of the biologic cycle of P. falciparum that may be relevant infected red blood cells to CD36 under flow is enhanced for the selective advantage conferred by this trait against by the cerebral malaria-protective trait South-East Asian malaria. In particular, SAO RBCs are partly resistant to in- ovalocytosis. Mol Biochem Parasitol 2005;142:252–7. vasion in culture by merozoites of Plasmodium knowlesi 13. O’Donnell A, Raiko A, Clegg JB, Weatherall DJ, Allen and several lines of P. falciparum,25,26 and the SAO trait SJ. Southeast Asian ovalocytosis and pregnancy in a also results in altered adhesion of infected RBCs to CD36. malaria-endemic region of Papua New Guinea. Am J As with ABO,27 it is likely that the evolutionary pressure ex- Trop Med Hyg 2007;76:631–3. erted by survival with SAO is related to survival of children 14. Benet A, Khong TY, Ura A, et al. Placental malaria in from cerebral malaria before reproductive age. Although Fy women with South-East Asian ovalocytosis. Am J Trop expression probably affects P. vivax infection,28 this evolu- Med Hyg 2006;75:597–604. tionary pressure is almost certainly caused by P. falciparum 15. Miller LH, Mason SJ, Clyde DF, et al. The resistance through its relationship to RBC adhesion. factor to Plasmodium vivax in blacks. The Duffy blood group genotype, FyFy. N Engl J Med 1976;295:302–4. Acknowledgment 16. Booth PB, Serjeantson S, Woodfield DG, Amato D. Se- This study was funded in part by a Covance Fellowship lective depression of blood group antigens associated from the Royal Australasian College of Physicians (I.W.). with hereditary ovalocytosis among Melanesians. Vox Sang 1977;32:99–110. References 17. Nichols ME, Rubenstein P, Barnwell J, et al. A new hu- 1. Haldane JBS. Disease and evolution. Ric Sci Suppl A man Duffy blood group specificity defined by a murine 1949;19:68–76. monoclonal antibody. Immunogenetics and association 2. Maitland K, Bejon P, Newton CR. Malaria. Curr Opin with susceptibility to Plasmodium vivax. J Exp Med Infect Dis 2003;16:389–95. 1987;166:776–85. 3. Jarolim P, Palek J, Amato D, et al. Deletion in erythro- 18. Wasniowksa K, Blanchard D, Janvier D, et al. Identifi- cyte band 3 gene in malaria-resistant Southeast Asian cation of the Fy6 epitope recognised by two monoclonal ovalocytosis. Proc Natl Acad Sci U S A 1991;88:11022– antibodies in the N-terminal extracellular portion of 6. the Duffy antigen receptor for chemokines. Mol Im- 4. Mgone CS, Koki G, Paniu MM, et al. Occurrence of the munol 1996;33:917–23. erythrocyte band 3 (AE1) gene deletion in relation to 19. Jarolim P, Palek J, Amato D, et al. Deletion in erythro- malaria endemicity in Papua New Guinea. Trans R Soc cyte band 3 gene in malaria-resistant Southeast Asian Trop Med Hyg 1996;90:228–31. ovalocytosis. Proc Natl Acad Sci U S A 1991;88:11022– 5. Genton B, al-Yaman F, Mgone CS, et al. Ovalocytosis 6. and cerebral malaria. Nature 1995;378:564–5. 20. Woolley IJ, Hotmire KA, Sramkoski RM, Zimmerman 6. Allen SJ, O’Donnell A, Alexander ND, et al. Prevention PA, Kazura JW. Differential expression of the Duffy of cerebral malaria in children in Papua New Guinea by antigen receptor for chemokines according to RBC age Southeast Asian ovalocytosis band 3. Am J Trop Med and FY genotype. Transfusion 2000;40:949–53. Hyg 1999;60:1056–60. 21. Michon P, Woolley I, Wood EM, Kastens W, Zimmer- 7. Fowkes FJ, Michon P, Pilling L, et al. Host erythrocyte man PA, Adams JH. Duffy-null promoter heterozygosi- polymorphisms and exposure to Plasmodium falcipar- ty reduces DARC expression and abrogates adhesion of um in Papua New Guinea. Malar J 2008;7:1. the P. vivax required for blood-stage infection. 8. Cattani JA, Gibson FD, Alpers MP, Crane GG. Heredi- FEBS Lett 2001;495:111–14. tary ovalocytosis and reduced susceptibility to malar- ia in Papua New Guinea. Trans R Soc Trop Med Hyg 1987;81:705–9.

IMMUNOHEMATOLOGY, Volume 25, Number 2, 2009 65 I.J. Woolley et al.

22. Beckmann R, Smythe JS, Anstee DJ, Tanner MJ. Coex- 27. Cserti CM, Dzik WH. The ABO blood group sys- pression of band 3 mutants and Rh polypeptides: dif- tem and Plasmodium falciparum malaria. Blood ferential effects of band 3 on the expression of the Rh 2007;110:2250–8. complex containing D polypeptide and the Rh complex 28. Kasehagen LJ, Mueller I, Kiniboro B, et al. Reduced containing CcEe polypeptide. Blood 2001;97:2496– Plasmodium vivax erythrocyte infection in PNG Duffy- 505. negative heterozygotes. PLoS ONE 2007;2:e336. 23. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Dis- ruption of a GATA motif in the Duffy gene promoter Ian J. Woolley (corresponding author), Department of abolishes erythroid in Duffy-negative Infectious Diseases, Monash Medical Centre and Monash individuals. Nat Genet 1995;10:224–8. University, Clayton, Victoria, Australia, Paul Hutchinson, 24. Cockburn IA, Mackinnon MJ, O’Donnell A, et al. A Centre for Inflammatory Diseases, Monash Medical Cen- human polymorphism that re- tre, Clayton, Victoria, Australia, John C. Reeder, Papua duces Plasmodium falciparum rosetting confers protec- New Guinea Institute of Medical Research, Goroka, Papua tion against severe malaria. Proc Natl Acad Sci U S A New Guinea (current affiliation: Burnet Institute, Prah- 2004;101:272–7. ran, Victoria, Australia), James W. Kazura, Center for 25. Kidson C, Lamont G, Saul A, Nurse GT. Ovalocytic Global Health & Diseases, Case Western Reserve Univer- erythrocytes from Melanesians are resistant to invasion sity, Cleveland, Ohio, USA, and Alfred Cortés, Papua New by malaria parasites in culture. Proc Natl Acad Sci U S Guinea Institute of Medical Research, Madang, Papua A 1981;78:5829–32. New Guinea (current affiliation: ICREA and Institute for 26. Hadley T, Saul A, Lamont G, Hudson DE, Miller LH, Research in Biomedicine, Barcelona, Spain). Kidson C. Resistance of Melanesian elliptocytes (ovalo- cytes) to invasion by Plasmodium knowlesi and Plas- modium falciparum malaria parasites in vitro. J Clin Invest 1983;71:780–2.

Manuscripts The editorial staff of Immunohematology welcomes manuscripts pertaining to blood group serology and educa- tion for consideration for publication. We are especially interested in case reports, papers on and white cell serology, scientific articles covering original investigations, and papers on new methods for use in the blood bank. Deadlines for receipt of manuscripts for consideration for the March, June, September, and December issues are the first weeks in November, February, May, and August, respectively. For instructions for scientific articles, case reports and review articles, see Instructions for Authors in every issue of Immunohematology or on the Web at www.redcross.org/immunohematology. Include fax and phone numbers and e-mail address with all articles and correspondence. E-mail all manuscripts to [email protected].

66 IMMUNOHEMATOLOGY, Volume 25, Number 2, 2009